The accumulation of 2-HG due to IDH1/2 mutations in AML has been linked to the accumulation of reactive oxygen species (ROS) and the depletion of cellular NADPH, thus creating distinct, IDH mutation-initiated metabolic states. Here, IDH1 is linked to acute myeloid leukemia.